VOLPI, CLAUDIA
 Distribuzione geografica
Continente #
NA - Nord America 1.968
EU - Europa 1.865
AS - Asia 578
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 4.428
Nazione #
US - Stati Uniti d'America 1.955
IT - Italia 600
IE - Irlanda 364
HK - Hong Kong 254
VN - Vietnam 200
RO - Romania 176
UA - Ucraina 159
SE - Svezia 152
FR - Francia 113
CN - Cina 87
DE - Germania 77
FI - Finlandia 60
RU - Federazione Russa 58
BE - Belgio 38
GB - Regno Unito 26
CH - Svizzera 15
TR - Turchia 14
CI - Costa d'Avorio 13
CA - Canada 12
GR - Grecia 9
NL - Olanda 9
IN - India 6
UZ - Uzbekistan 5
JP - Giappone 4
LB - Libano 4
AT - Austria 3
EU - Europa 3
PL - Polonia 3
CZ - Repubblica Ceca 2
SG - Singapore 2
AU - Australia 1
HU - Ungheria 1
IR - Iran 1
KR - Corea 1
MX - Messico 1
Totale 4.428
Città #
Chandler 412
Perugia 378
Dublin 359
Hong Kong 254
Dong Ket 200
San Mateo 194
Bucharest 175
Redmond 122
Medford 79
Wilmington 79
Altamura 78
Princeton 78
Jacksonville 77
Ann Arbor 63
Lawrence 62
Beijing 55
Andover 50
Falls Church 43
Brussels 38
Dearborn 33
Des Moines 30
Pisa 26
Los Angeles 23
Norwalk 22
Saint Petersburg 22
Ashburn 16
Fremont 15
Woodbridge 15
Izmir 14
San Paolo di Civitate 14
Abidjan 13
Boardman 13
Redwood City 11
San Diego 9
Den Haag 7
Helsinki 7
Nanjing 7
Hefei 6
New York 6
Hanover 5
Menlo Park 5
Ottawa 5
Terni 5
Chicago 4
Dallas 4
Fairfield 4
Florence 4
Houston 4
Rome 4
Saint Louis 4
Spoleto 4
West Jordan 4
Winnipeg 4
Auburn Hills 3
Esslingen am Neckar 3
Falkenstein 3
Nichelino 3
Nürnberg 3
Paris 3
Simi Valley 3
Toronto 3
Baotou 2
Chennai 2
Collazzone 2
Frankfurt Am Main 2
Jinan 2
Kunming 2
Kālpākkam 2
Lappeenranta 2
Ludwigshafen 2
Milan 2
Monreale 2
Ningbo 2
Planegg 2
San Jose 2
San Pietro Mosezzo 2
Shenyang 2
Silea 2
Tappahannock 2
Trieste 2
Wako 2
Amsterdam 1
Assisi 1
Athens 1
Azcapotzalco 1
Bastia umbra 1
Boydton 1
Bragadiru 1
Budapest 1
Carrollton 1
Castel Maggiore 1
Castiglione del Lago 1
Chengdu 1
Civitanova Marche 1
Corciano 1
Edinburgh 1
Freiburg 1
Fuzhou 1
Groningen 1
Guangzhou 1
Totale 3.248
Nome #
Allosteric modulation of metabotropic glutamate receptor 4 activates IDO1-dependent, immunoregulatory signaling in dendritic cells 131
Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1. 123
A GpC-Rich Oligonucleotide Acts on Plasmacytoid Dendritic Cells To Promote Immune Suppression. 116
Aryl hydrocarbon receptor control of a disease tolerance defence pathway. 114
A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells 113
Class IA PI3Ks regulate subcellular and functional dynamics of IDO1 111
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 106
Amino-acid sensing and degrading pathways in immune regulation 103
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 102
IL‐35Ig–expressing dendritic cells induce tolerance via Arginase 1 100
Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1 97
Amino acid metabolism as drug target in autoimmune diseases 94
Advances in indoleamine 2,3-dioxygenase 1 medicinal chemistry 90
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 85
The TGF-β/IDO axis in infectious tolerance. 84
Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes 83
Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans. 80
Dendritic cells expressing ectopic IL-35Ig induce IDO-related tolerance in vivo. 79
Aryl hydrocarbon Receptor and RelB control long term expression of Indoleamine 2,3-dioxygenase-1 in endotoxin tolerance 75
Artocarpus tonkinensis extract inhibits LPS-triggered inflammation markers and suppresses RANKL-induced osteoclastogenesis in RAW264.7 74
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 72
Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1 in juvenile diabetes 71
A novel metabotropic glutamate receptor 4 allosteric modulator effective in multiple sclerosis experimental autoimmune encephalomyelitis (EAE) mouse model 70
A TLR9/TRIF pathway induces tolerance via TGF-beta and tryptophan catabolism in plasmacytoid dendritic cells 69
Preclinical discovery and development of fingolimod for the treatment of multiple sclerosis 69
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 67
Antigen-specific immunoregulation by IL-35Ig-transfected dendritic cells 65
Onion (Allium cepa L.) Skin: A rich resource of biomolecules for the sustainable production of colored biofunctional textiles 65
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 62
High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9-TRIF pathway. 61
Islet antigen-pulsed dendritic cells expressing ectopic IL-35Ig protect nonobese diabetic mice from autoimmune diabetes. 58
Ectopic expression of IL-35Ig by dendritic cells induces tolerance via Arginase 1. 58
Use of a Zwitterionic Surfactant to Improve the Biofunctional Properties of Wool Dyed with an Onion (Allium cepa L.) Skin Extract 58
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 56
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 54
Reinstalling immune regulatory tryptophan catabolism in juvenile diabetes via interleukin 6 receptor blockade 53
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in a resected non-small cell lung cancer series 53
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 51
Ectopic expression of IL-35Ig by dendritic cells induces IDO-related tolerance in vivo 51
CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis 51
CTLA-4-immunoglobulin and indoleamine 2,3 dioxygenase in dominant tolerance. 49
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 46
Generation of protective immune environment in murine models of Multiple Sclerosis by TLR7 and TLR9 agonists 46
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice. 45
IDO mediates TLR9-driven protection from experimental autoimmune diabetes 44
Challenges in the design of reliable immuno-oncology mouse models to inform drug development 43
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation 42
Proteasomal Degradation of Indoleamine 2,3-Dioxygenase in CD8 Dendritic Cells is Mediated by Suppressor of Cytokine Signaling 3 (SOCS3). 41
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 41
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 41
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 41
The role of TGF-beta as tolerogenic cytokine in regulating dendritic cell function. 40
Targeting metabotropic glutamate receptors for the treatment of neuroinflammation 40
Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation 39
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 39
Anti-osteoclastogenic activity of Crocus sativus petal extract: turning saffron waste into a valuable resource against bone disruption. 39
Reply to Han et al.: On track for an IDO1-based personalized therapy in autoimmunity 38
Effect of Probiotic Administration on Serum Tryptophan Metabolites in Pediatric Type 1 Diabetes Patients 38
The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes. 37
Endotoxin tolerance as a novel defense strategy in infectious diseases: the role of tryptophan catabolism 36
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 35
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 35
Crocus sativus L. Petal Extract Inhibits Inflammation and Osteoclastogenesis in RAW 264.7 Cell Model 35
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 34
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 34
Differentiation of Myeloid-derived Suppressor Cells from Murine Bone Marrow and Their Co-culture with Splenic Dendritic Cells 34
Indoleamine 2,3-dioxygenase: from catalyst to signaling function 31
Vedere per credere: utilizzo della microscopia per lo studio dell’immunologia 31
In-depth characterization of phenolic profiling of Moraiolo extra-virgin olive oil extract and initial investigation of the inhibitory effect on Indoleamine-2,3-Dioxygenase (IDO1) enzyme 28
Targeting metabotropic glutamate receptors in neuroimmune communication 26
A TLR9/TRIF PATHWAY INDUCES TOLERANCE VIA TGF-β AND TRYPTOPHAN CATABOLISM IN PLASMACYTOID DENDRITIC CELLS 26
Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4 25
Potential prognostic role of Indoleamine 2,3-dioxygenase 2 in human non-small cell lung cancer: an immunohistochemical study. 24
A TLR9/TRIF PATHWAY INDUCES TOLERANCE VIA TGF-β AND TRYPTOPHAN CATABOLISM IN PLASMACYTOID DENDRITIC CELLS 24
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma 23
PROTEASOME INHIBITION IN pDCs CONFERS AN IDO-DEPENDENT IMMUNOREGULATORY PHENOTYPE 23
A back-door insight into the modulation of Src kinase activity by the polyamine spermidine 22
IDO-TARGETING INTERVENTION IN AUTOIMMUNE DIABETES BY PROTEASOME INHIBITION 22
Antioxidant power on dermal cells by textiles dyed with an onion (Allium cepa L.) skin extract 21
Cytotoxic T lymphocyte antigen 4-immunoglobulin G is a potent adjuvant for experimental allergen immunotherapy. 20
Current Challenges for IDO2 as Target in Cancer Immunotherapy 20
Indoleamine 2,3 dioxygnenase: as an inducer and amplifier of regulatory T cell functions. 19
Decoding the Complex Crossroad of Tryptophan Metabolic Pathways 19
Optimization of Ultrasound-Assisted Extraction of Chlorogenic Acid from Potato Sprout Waste and Enhancement of the In Vitro Total Antioxidant Capacity 17
Optimization of a Simple Analytical Workflow to Characterize the Phenolic Fraction from Grape Pomace 16
Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme 14
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1 11
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 11
Analysis of Differential TLR Activation in a Mouse Model of Multiple Sclerosis 10
MARS: A Multipurpose Software for Untargeted LC–MS-Based Metabolomics and Exposomics 10
Membrane Localization and Phosphorylation of Indoleamine 2,3-Dioxygenase 2 (IDO2) in A549 Human Lung Adenocarcinoma Cells: First Steps in Exploring Its Signaling Function 7
The double life of serotonin metabolites: in the mood for joining neuronal and immune systems 7
Modulation of Indoleamine 2,3-Dioxygenase 1 During Inflammatory Bowel Disease Activity in Humans and Mice 7
Chromatographic measurement of 3-hydroxyanthranilate 3,4-dioxygenase activity reveals that edaravone can mitigate the formation of quinolinic acid through a direct enzyme inhibition 6
Volumetric Absorptive Microsampling (VAMS) for Targeted LC-MS/MS Determination of Tryptophan-Related Biomarkers 3
Editorial: Heme proteins: key players in the regulation of immune responses 1
Totale 4.730
Categoria #
all - tutte 16.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201926 0 0 0 0 0 0 0 0 0 0 18 8
2019/2020440 20 13 48 10 42 42 47 30 83 44 23 38
2020/2021808 5 33 18 30 230 37 86 11 74 33 39 212
2021/20221.125 9 145 19 26 36 29 17 213 133 151 100 247
2022/20231.351 84 258 18 114 118 126 4 61 481 16 54 17
2023/2024519 48 74 24 10 20 17 199 17 78 32 0 0
Totale 4.730